IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans

Association between low density lipoprotein and rheumatoid arthritis genetic factors with low density lipoprotein levels in rheumatoid arthritis and non-rheumatoid arthritis controls

(2013) Katherine P Liao et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study

(2013) Iain B McInnes et al.   ANNALS OF THE RHEUMATIC DISEASES

Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis

(2013) Aart C. Strang et al.   ATHEROSCLEROSIS

Hyperlipoproteinemia(a): Clinical significance and treatment options

(2013) Heiner K. Berthold et al.   ATHEROSCLEROSIS SUPPLEMENTS

DNA Methylation Analysis in Nonalcoholic Fatty Liver Disease Suggests Distinct Disease-Specific and Remodeling Signatures after Bariatric Surgery

(2013) Markus Ahrens et al.   Cell Metabolism

The Role of Niacin in Lipid-lowering Treatment: Are we Aiming Too High?

(2013) Ioanna Gouni-Berthold et al.   CURRENT PHARMACEUTICAL DESIGN

Hepatic acute phase proteins – Regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling

(2011) Johannes G. Bode et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Tristetraprolin Mediates Anti-inflammatory Effects of Nicotine in Lipopolysaccharide-stimulated Macrophages

(2011) Yeonsoo Joe et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Optimal therapy for reduction of lipoprotein(a)

(2011) G. Lippi et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Association between the Interleukin-6 Promoter Polymorphism −174G/C and Serum Lipoprotein(a) Concentrations in Humans

(2011) Heiner K. Berthold et al.   PLoS One

High plasma levels of apo(a) fragments in Caucasians and African-Americans with end-stage renal disease: implications for plasma Lp(a) assay

(2010) Vincent Mooser et al.   CLINICAL GENETICS

Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases

(2010) Olaf Schultz et al.   PLoS One